PTPN2 has previously been linked to MS as a microRNA, i.e. miR-448, that was upregulated in PBMC and cerebrospinal fluid (CSF) from MS patients, promoted IL-17 production directly through PTPN2, thereby contributing to development of an autoinflammatory immune environment. This evidence concerns the gene IL17A and myeloid sarcoma.